Hacker News new | ask | show | jobs
by Kye 301 days ago
There is a third path where the traditional thing can't be commercialized so modern medicine doesn't pursue it. A (sincere) traditional practitioner might be less concerned with gaining and exploiting a patent, so the commercial potential isn't as important.

Telling that person apart from the sea of charlatans complicates things a bit. They're not the people who launch their careers with Oprah's help and spawn a million others riding in their wake.

1 comments

That’s a thought terminating cliche. Academia doesn’t care about commercialization, they care about grants and they don’t much care which organization it comes from. You can argue why they don’t make it to market as FDA regulated medicines but not why there’s no positive evidence for their efficacy.

> Telling that person apart from the sea of charlatans complicates things a bit.

Peer review (for all its faults) and clinical trials that inform evidence based medicine. That’s how you tell them apart.